A randomized, double-blind, placebo-controlled trial of the human anti-TNF-α monoclonal antibody adalimumab for the induction of remission in patients with moderate to severely active Crohn's disease

被引：32

作者：

Hanauer, S

Lukás, M

MacIntosh, D

Rutgeerts, P

Sandborn, W

Pollack, P

机构：

[1] Univ Chicago, Chicago, IL 60637 USA

[2] Charles Univ Prague, Prague, Czech Republic

[3] Dalhousie Univ, Halifax, NS B3H 3J5, Canada

[4] UZ Gasthuisberg, Gasthuisberg, Belgium

[5] Abbott Labs, Abbott Pk, IL 60064 USA

来源：

关键词：

D O I：

10.1053/j.gastro.2004.05.010

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：332 / 332

页数：1